Published • loading... • Updated
Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval
Summary by Verdict Hospital
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval
Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.The post Devonian’s Phase II/III Thykamine paediatric study secures Health Canada approval appeared first on Hospital Management.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
